Is NPAT up or down today?
NPAT is up 1.25% today, last at 249.61. This stock moved +1.25% versus the prior close.
NPAT · NPAT
NPAT (NPAT) is trading at 249.61, up 1.25% on the session. NPAT sits at the 50% mark of its 52-week range, carries a 14-day RSI of 47, and trades below its 50-day average. Over the past month it is up 2.64%.
Leading the coverage: “Resimac Group (ASX:RMC) Shares Ease as FY26 Normalised NPAT Climbs 26% to $49.9 Million - Kalkine” (Google News Company, 6d ago). NPAT is -3.30% since story.
NPAT trades on a trailing P/E of 34.8 and is running 3.58% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
NPAT is up 1.25% today, last at 249.61. This stock moved +1.25% versus the prior close.
Leading the coverage: “Resimac Group (ASX:RMC) Shares Ease as FY26 Normalised NPAT Climbs 26% to $49.9 Million - Kalkine” (Google News Company, 6d ago). NPAT is -3.30% since story. Dominant story: Resimac Group (ASX:RMC) Shares Ease as FY26 Normalised NPAT Climbs 26% to $49.9 Million - Kalkine (2 sources, neutral) RSI is 47 — neutral Price below 50-day average — short-term weakness Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (181 days) · Drag or scroll left for earlier dates
Resimac Group (ASX:RMC) Shares Ease as FY26 Normalised NPAT Climbs 26% to $49.9 Million - Kalkine
Regal Partners (ASX:RPL) Share Price Down 18% in 5 Days: Does 108% NPAT Growth Make This a Buying Opportunity? - Kalkine
Corporate Travel Management (ASX:CTD) Returns to Profit with FY26 NPAT of $17.7 Million - Kalkine
Simonds Group Reports $10.5 Million NPAT and $729.1 Million Revenue for FY26 - Kalkine
Monash IVF (ASX:MVF) Posts Revenue of $269.5M in FY26, NPAT Falls 41% Amid Domestic Volume Pressures - Kalkine